default author photo

Ekaterina V. Kurbatova

Centers for Disease Control and Prevention (U.S.

SCHOLARLY PAPERS

1

DOWNLOADS

55

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Final 18-month Outcomes of a Trial of Four-Month Rifapentine Regimens With or Without Moxifloxacin for Tuberculosis

Number of pages: 18 Posted: 20 Feb 2026
University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Centers for Disease Control and Prevention (U.S., Medical University of South Carolina, Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Vanderbilt University - Medical Center, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Case Western Reserve University, Bio Analytical Research Corporation South Africa (BARC SA), National Lung Hospital, Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Johns Hopkins University, University of Nebraska Medical Center and University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis
Downloads 55 (1,010,164)

Abstract:

Loading...

tuberculosis, non-inferiority, rifapentine, moxifloxacin